CGEM Cullinan Oncology LLC

USD 16.45 0.00 0
Icon

Cullinan Oncology LLC (CGEM) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 16.45

0.00 (0.00)%

USD 0.93B

0.47M

USD 32.00(+94.53%)

N/A

Icon

CGEM

Cullinan Oncology LLC (USD)
COMMON STOCK | NSD
USD 16.45
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.93B

N/A

USD 16.45

Cullinan Oncology LLC (CGEM) Stock Forecast

Show ratings and price targets of :
USD 32.00
(+94.53%)

Based on the Cullinan Oncology LLC stock forecast from 4 analysts, the average analyst target price for Cullinan Oncology LLC is USD 32.00 over the next 12 months. Cullinan Oncology LLC’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Cullinan Oncology LLC is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Cullinan Oncology LLC’s stock price was USD 16.45. Cullinan Oncology LLC’s stock price has changed by +1.67% over the past week, -12.87% over the past month and +40.36% over the last year.

No recent analyst target price found for Cullinan Oncology LLC
No recent average analyst rating found for Cullinan Oncology LLC

Company Overview Cullinan Oncology LLC

Cullinan Therapeutics, Inc., a biopharmaceutical company, focuses on developing oncology therapies for cancer patients in the United States. The company's lead program comprises CLN-619, a monoclonal antibody that is in Phase I clinical trial for the treatment of solid tumors. It...Read More

One Main Street, Cambridge, MA, United States, 02142

85

December

USD

USA

Adjusted Closing Price for Cullinan Oncology LLC (CGEM)

Loading...

Unadjusted Closing Price for Cullinan Oncology LLC (CGEM)

Loading...

Share Trading Volume for Cullinan Oncology LLC Shares

Loading...

Compare Performance of Cullinan Oncology LLC Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CGEM

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Cullinan Oncology LLC (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD127.00B 31.94 20.00

ETFs Containing CGEM

Symbol Name CGEM's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Cullinan Oncology LLC (CGEM) Stock

Based on ratings from 4 analysts Cullinan Oncology LLC's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 6 buy, sell and hold ratings.

Unfortunately we do not have enough data on CGEM's stock to indicate if its a good dividend stock.

Based on targets from 4 analysts, the average taret price for CGEM is USD 32.00 over the next 12 months. The maximum analyst target price is USD 40 while the minimum anlayst target price is USD 28.

CGEM stock's Price/Earning ratio is 9.03. Our analysis grades CGEM stock's Price / Earning ratio at F. This means that CGEM stock's Price/Earning ratio is above 53% of the stocks in the Biotechnology sector in the NSD exchange. Based on this CGEM may be a overvalued for its sector.

The last closing price of CGEM's stock was USD 16.45.

The most recent market capitalization for CGEM is USD 0.93B.

Based on targets from 4 analysts, the average taret price for CGEM is projected at USD 32.00 over the next 12 months. This means that CGEM's stock price may go up by +94.53% over the next 12 months.

We can't find any ETFs which contains Cullinan Oncology LLC's stock.

As per our most recent records Cullinan Oncology LLC has 85 Employees.

Cullinan Oncology LLC's registered address is One Main Street, Cambridge, MA, United States, 02142. You can get more information about it from Cullinan Oncology LLC's website at https://www.cullinanoncology.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...